The combined presence of the quinoxaline HBY097 and 3TC results in potent suppression of AZT-resistant HIV-1 strains

Jan Balzarini; Heidi Pelemans; G Riess; Manfred Roesner; Irvin Winkler; De Clercq Erik; J P Kleim

doi:10.1016/s0166-3542(97)83197-x

Related publications

Article1996

In vitro selection of high level quinoxaline (HBY097) resistance using a patient isolate displaying a multidrug resistant phenotype

Anne‐Mieke Vandamme, JC Schmit, Jan Balzarini, Myriam Witvrouw, K VanLaethem, J. Kleim, Jan Desmyter, De Clercq Erik

Article2001

“SECOND GENERATION” OF TSAO COMPOUNDS DIRECTED AGAINST HIV-1 TSAO-RESISTANT STRAINS

Esther Lobatón, Sonsoles Velázquez, María‐Jesús Pérez‐Pérez, M. Luísa Jimeno, Ana San‐Félix, De Clercq Erik, Jan Balzarini, Marı́a-José Camarasa

Letter2000

Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir

Kristel Van Laethem, Myriam Witvrouw, Jan Balzarini, Jean‐Claude Schmit, S Sprecher, Philippe Hermans, Manuel Leal, Thomas Harrer, Lı́dia Ruiz, Bonaventura Clotet, Marc Van Ranst, Jan Desmyter, De Clercq Erik, Anne‐Mieke Vandamme

Article2001

ChemInform Abstract: “Second Generation” of TSAO Compounds Directed Against HIV‐1 TSAO‐Resistant Strains

Esther Lobatón, Sonsoles Velázquez, María‐Jesús Pérez‐Pérez, M. Luísa Jimeno, Ana San‐Félix, De Clercq Erik, Jan Balzarini, Marı́a-José Camarasa

Article1995

Synthesis and Anti-HIV Activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] Dimers as Potential Multifunctional Inhibitors of HIV-1 Reverse Transcriptase

Sonsoles Velázquez, Rosa Álvarez, Ana San‐Félix, M. Luísa Jimeno, De Clercq Erik, Jan Balzarini, Marı́a-José Camarasa